Inscripta raises $55.5M to advance gene-editing tech

Inscripta raises $55.5M to advance gene-editing tech

BOULDER -- Inscripta , a leading gene-editing technology company, announced it closed a $55.5 million Series C funding round led by Merieux Developpement and Paladin Capital Group. ... Read More

Wednesday February 28, 2018 0 comments Tags: Boulder, Inscripta, Dr. Kevin Ness, gene editing